Bristol-Myers Squibb to Hold Investor Event to Discuss ASCO Highlights

May 24, 2018

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will hold an investor event on Monday, June 4, 2018 at 8:30 p.m. EDT (7:30 p.m. CDT) to discuss data presented at the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data presented from the company’s oncology portfolio, and address questions from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the event at Materials related to the event will be available at the same website prior to the event. A replay of the event will be available and can be accessed at

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at or follow us on LinkedInTwitter, YouTube and Facebook.

Source: Bristol-Myers Squibb Company

Bristol-Myers Squibb Company


Ken Dominski, 609-252-5251


Lisa McCormick Lavery, 609-252-7602



Tim Power, 609-252-7509


Bill Szablewski, 609-252-5894